Download video

ASH24 - 6 Impact of Socioeconomic Factors on Access to and Outcomes of allo-HCT for AML

16 views

Oncoletter

1 month ago

ASH24 - 6 Impact of Socioeconomic Factors on Access to and Outcomes of allo-HCT for AML

ASH24 - 6 Impact of Socioeconomic Factors on Access to and Outcomes of allo-HCT for AML

ASH24 - 6 Impact of Socioeconomic Factors on Access to and Outcomes of allo-HCT for AML
7:54
ASH24 - 6 Impact of Socioeconomic Factors on Access to and Outcomes of allo-HCT for AML
by Oncoletter
Impact of Socioeconomic Factors on Access to allo-HCT for AML
4:01
Impact of Socioeconomic Factors on Access to allo-HCT for AML
by EmatoInfoTV
Addressing Socioeconomic Challenges in Acute Myeloid Leukemia Treatment | Mohamed Sorror, MD |#ASH24
8:21
Addressing Socioeconomic Challenges in Acute Myeloid Leukemia Treatment | Mohamed Sorror, MD |#ASH24
by HealthTree Foundation for Blood Cancers
Outcomes of alloSCT for AML with WT1 mutation
2:13
Outcomes of alloSCT for AML with WT1 mutation
by VJHemOnc – Video Journal of Hematology \& HemOnc
How Self-Rated Health Impacts Patient Outcomes| Nora Balas, PhD | #ASH24
3:05
How Self-Rated Health Impacts Patient Outcomes| Nora Balas, PhD | #ASH24
by HealthTree Foundation for Blood Cancers
The impact of cytogenetic-risk stratification on AML outcomes
3:47
The impact of cytogenetic-risk stratification on AML outcomes
by VJHemOnc – Video Journal of Hematology \& HemOnc
Using an AI model to quantify under-utilization of alloSCT for AML in the UK
1:17
Using an AI model to quantify under-utilization of alloSCT for AML in the UK
by VJHemOnc – Video Journal of Hematology \& HemOnc
BEAT AML: PERSONALIZED TREATMENT FOR DEADLY BLOOD AND BONE MARROW CANCER
1:17
BEAT AML: PERSONALIZED TREATMENT FOR DEADLY BLOOD AND BONE MARROW CANCER
by Ivanhoe Web
Comparing real-world outcomes with CPX-351 versus fludarabine-based induction in secondary AML
1:19
Comparing real-world outcomes with CPX-351 versus fludarabine-based induction in secondary AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Frailty’s Impact on Outcomes in Older MM Patients Treated with Bispecifics | Nadine Abdallah| #ASH24
2:44
Frailty’s Impact on Outcomes in Older MM Patients Treated with Bispecifics | Nadine Abdallah| #ASH24
by HealthTree Foundation for Multiple Myeloma
Considerations when selecting patients over 70 with AML for transplantation
2:44
Considerations when selecting patients over 70 with AML for transplantation
by VJHemOnc – Video Journal of Hematology \& HemOnc
Individualized machine learning predictions of alloSCT outcomes in AML: the HARMONY platform
1:47
Individualized machine learning predictions of alloSCT outcomes in AML: the HARMONY platform
by VJHemOnc – Video Journal of Hematology \& HemOnc
Improving AML outcomes
3:03
Improving AML outcomes
by VJHemOnc – Video Journal of Hematology \& HemOnc
AML relapse after HSCT: trends and predictive factors
3:17
AML relapse after HSCT: trends and predictive factors
by VJHemOnc – Video Journal of Hematology \& HemOnc
Outcomes \& treatment options for patients with AML who relapse after alloHSCT
1:40
Outcomes \& treatment options for patients with AML who relapse after alloHSCT
by VJHemOnc – Video Journal of Hematology \& HemOnc
ASH 2024: David Sallman, MD on MRD Evaluation via NGS with CPX-351 in Acute Myeloid Leukemia
2:38
ASH 2024: David Sallman, MD on MRD Evaluation via NGS with CPX-351 in Acute Myeloid Leukemia
by Moffitt Cancer Center
The impact of induction therapy on post-transplant outcomes in AML
2:50
The impact of induction therapy on post-transplant outcomes in AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Optimizing haplo-SCT for the treatment of AML
2:25
Optimizing haplo-SCT for the treatment of AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Indications for autologous stem cell transplantation in AML
1:23
Indications for autologous stem cell transplantation in AML
by VJHemOnc – Video Journal of Hematology \& HemOnc
Prognostic impact of WT1 mutations in newly diagnosed and R\/R AML
1:33
Prognostic impact of WT1 mutations in newly diagnosed and R\/R AML
by VJHemOnc – Video Journal of Hematology \& HemOnc